All Stories

  1. Deeper Insight in Metastatic Cancer Progression; Epithelial-to- Mesenchymal Transition and Genomic Instability: Implications on Treatment Resistance

    Article • Current Molecular Medicine, November 2021, Bentham Science Publishers

    Maxwell Omabe

  2. Emerging Metabolomics Biomarkers of Polycystic Ovarian Syndrome; Targeting the Master Metabolic Disrupters for Diagnosis and Treatment

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, April 2018, Bentham Science Publishers

    Maxwell Omabe

  3. Metabolic Basis of Polycystic Ovarian Syndrome; Indications for Biochemical Screening

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, May 2016, Bentham Science Publishers

    Maxwell Omabe, Dr Ademola C Famurewa

  4. Non Selective Inhibition of COX Activity Reversed Inflammation and Reactive Oxygen Radicals Mediated Prostate Cancer Risk and Decreased Disease Progression in Preclinical Model

    Article • Journal of Cancer Therapy, January 2016, Scientific Research Publishing, Inc,

    Maxwell Omabe, Dr Ademola C Famurewa

  5. Lipid metabolism and cancer progression: The missing target in metastatic cancer treatment

    Article • Journal of Applied Biomedicine, February 2015, Elsevier

    Maxwell Omabe

  6. Metabolic Basis of Treatment Failures; Autophagy and Malignant Cancer Progression

    Article • Journal of Clinical & Experimental Oncology, January 2013, OMICS Publishing Group

    Maxwell Omabe